Search Results - "Mutschler, Jochen"

Refine Results
  1. 1

    Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review by Fischler, Pascal Valentin, Soyka, Michael, Seifritz, Erich, Mutschler, Jochen

    Published in Frontiers in pharmacology (03-10-2022)
    “…Compounds known to be successful in the treatment of alcohol use disorder include the aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist,…”
    Get full text
    Journal Article
  2. 2

    Technostress and Digital Competence Among Health Professionals in Swiss Psychiatric Hospitals: Cross-sectional Study by Golz, Christoph, Peter, Karin Anne, Müller, Thomas Jörg, Mutschler, Jochen, Zwakhalen, Sandra M G, Hahn, Sabine

    Published in JMIR mental health (01-11-2021)
    “…Background Psychiatric hospitals are becoming increasingly digitized because of the disruptive rise in technical possibilities. This digitization leads to new…”
    Get full text
    Journal Article
  3. 3

    Stigma as a Barrier to Mental Health Service Use Among Female Sex Workers in Switzerland by Zehnder, Mara, Mutschler, Jochen, Rössler, Wulf, Rufer, Michael, Rüsch, Nicolas

    Published in Frontiers in psychiatry (05-02-2019)
    “…Many sex workers suffer from mental health problems, but do not seek help. To examine stigma-related and non stigma-related barriers to care and perceived need…”
    Get full text
    Journal Article
  4. 4

    Conversation-based AI for anxiety disorders might lower the threshold for traditional medical assistance: a case report by Grosshans, Martin, Paul, Torsten, Fischer, Sebastian Karl Maximilian, Lotzmann, Natalie, List, Hannah, Haag, Christina, Mutschler, Jochen

    Published in Frontiers in public health (20-09-2024)
    “…Artificial intelligence (AI) offers a wealth of opportunities for medicine, if we also bear in mind the risks associated with this technology. In recent years…”
    Get full text
    Journal Article
  5. 5

    Pregabalin use in forensic hospitals and prisons in German speaking countries-a survey study of physicians by Novotny, Michal, Bulla, Jan, Hubl, Daniela, Fischer, Sebastian Karl Maximilian, Grosshans, Martin, Gutzeit, Andreas, Bilke-Hentsch, Oliver, Seifritz, Erich, Mutschler, Jochen

    Published in Frontiers in public health (08-01-2024)
    “…Pregabalin is a gamma-aminobutyric acid (GABA) analog that was approved in the EU in 2004 for the treatment of neuropathic pain, generalized anxiety disorder…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Dextromethorphan withdrawal and dependence syndrome by Mutschler, Jochen, Koopmann, Anne, Grosshans, Martin, Hermann, Derik, Mann, Karl, Kiefer, Falk

    Published in Deutsches Ärzteblatt international (01-07-2010)
    “…The N-methyl-D-aspartate (NMDA) antagonist dextromethorphan has been available in pharmacies without a prescription since 1954 as an antitussive agent. There…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine by Soyka, Michael, Mutschler, Jochen

    “…Substance use disorders are common, but only a small minority of patients receive adequate treatment. Although psychosocial therapies are effective, relapse is…”
    Get full text
    Journal Article
  10. 10

    Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience by Grosshans, Martin, Mutschler, Jochen, Kiefer, Falk

    Published in International clinical psychopharmacology (01-07-2015)
    “…The treatment of cocaine dependence is difficult as no approved pharmacotherapy is available as yet. However, in preclinical and clinical trials, a variety of…”
    Get full text
    Journal Article
  11. 11

    Pregabalin abuse and dependence in various European countries: Association with substitution policies by Kuhn, Dominique, Müller, Thomas Jörg, Mutschler, Jochen

    Published in Fortschritte der Neurologie-Psychiatrie (01-11-2021)
    “…Pregabalin was first approved in 2004 for the treatment of peripheral neuropathic pain and focal epileptic seizures, with or without secondary generalization…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Pregabalin abuse among opiate addicted patients by Grosshans, Martin, Lemenager, Tagrid, Vollmert, Christian, Kaemmerer, Nina, Schreiner, Rupert, Mutschler, Jochen, Wagner, Xenija, Kiefer, Falk, Hermann, Derik

    Published in European journal of clinical pharmacology (01-12-2013)
    “…Purpose Pregabalin is a novel GABA-analogue approved for the treatment of partial onset seizures, neuropathic pain, and general anxiety disorder. Pregabalin…”
    Get full text
    Journal Article
  14. 14

    Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision by Soyka, Michael, Kranzler, Henry R., Hesselbrock, Victor, Kasper, Siegfried, Mutschler, Jochen, Möller, Hans-Jürgen

    Published in The world journal of biological psychiatry (01-03-2017)
    “…These practice guidelines for the biological treatment of alcohol use disorders are an update of the first edition, published in 2008, which was developed by…”
    Get full text
    Journal Article
  15. 15

    Pregabalin Abuse, Dependence, and Withdrawal: A Case Report by Grosshans, Martin, Mutschler, Jochen, Hermann, Derik, Klein, Oliver, Dressing, Harald, Kiefer, Falk, Mann, Karl

    Published in The American journal of psychiatry (01-07-2010)
    “…A breathalyzer test for alcohol was negative, urine drug test was positive for cannabis, and the patient stated that alcohol withdrawal symptoms were unknown…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Psychiatric Comorbidity and Psychopathology of Methamphetamine Users—Are There Gender Differences? by Franke, Andreas G., Neumann, Stefanie, Proebstl, Lisa, Kamp, Felicia, Hager, Laura, Manz, Kirsi, Krause, Daniela, Mutschler, Jochen, Koller, Gabi, Soyka, Michael

    “…Methamphetamine use disorder is associated with severe psychiatric symptoms and psychosocial problems. Women seem to be more affected than men. Therefore, this…”
    Get full text
    Journal Article
  18. 18

    Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients by Grosshans, Martin, Mutschler, Jochen, Luderer, Mathias, Mann, Karl, Kiefer, Falk

    Published in Clinical neuropharmacology (01-01-2014)
    “…Sleep disorders are a widespread, persistent problem among alcohol-dependent patients and have been implicated in an increased risk for alcohol relapse. The…”
    Get full text
    Journal Article
  19. 19

    The natriuretic peptide system as a possible therapeutic target for stress-induced obesity by Mutschler, Jochen, Kiefer, Falk

    Published in Medical hypotheses (01-03-2011)
    “…Abstract Genetic and environmental influences are both known to be causal factors in the development and maintenance of obesity. Stress related chronic…”
    Get full text
    Journal Article
  20. 20